Results 121 to 130 of about 1,533 (199)

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers. [PDF]

open access: yesProc Natl Acad Sci U S A
Tendler S   +18 more
europepmc   +1 more source

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis. [PDF]

open access: yesBone Jt Open
Smolle MA   +441 more
europepmc   +1 more source

Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models. [PDF]

open access: yesJ Nucl Med
Hoang TT   +14 more
europepmc   +1 more source

Evaluating NIR-II-Emissive Graphene Quantum Dot Biodistribution, Toxicity, and Clearance for <i>In Vivo</i> Fluorescence Imaging. [PDF]

open access: yesACS Appl Nano Mater
Valimukhametova A   +10 more
europepmc   +1 more source

Editorial: Nanomedicine targeting central nervous system. [PDF]

open access: yesFront Med (Lausanne)
Yadav TC, Yadav-Samudrala BJ, Fitting S.
europepmc   +1 more source

Validation of nine prognostic models in patients with bone metastases undergoing surgery. [PDF]

open access: yesJ Orthop Surg Res
Smolle MA   +7 more
europepmc   +1 more source

Brain Metastases in Diffuse Pleural Mesothelioma: Clinical, Histologic, and Molecular Correlates. [PDF]

open access: yesJTO Clin Res Rep
Ocejo A   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy